{"id":28633,"date":"2020-07-14T10:09:58","date_gmt":"2020-07-14T10:09:58","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=28633"},"modified":"2020-07-14T10:09:58","modified_gmt":"2020-07-14T10:09:58","slug":"parkinsons-plus-syndromes","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/parkinsons-plus-syndromes\/","title":{"rendered":"\u201cParkinson\u2019s Plus\u201d syndromes"},"content":{"rendered":"

The atypical parkinsonian syndromes\u2014dementia with lewy bodies, multiple system atrophy, progressive supranuclear palsy, and corticobasal ganglionic degeneration\u2014are often difficult to differentiate from parkinson\u2019s disease and each other. Although these syndromes are clinically distinct, modern immunocytochemical techniques and new genetic findings have revealed intriguing interconnections at a basic molecular level, providing a scientific rationale for lumping these diseases into two groups, the synucleinopathies and the tauopathies.<\/p>\n

\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

The atypical parkinsonian syndromes\u2014dementia with lewy bodies, multiple system atrophy, progressive supranuclear palsy, and corticobasal ganglionic degeneration\u2014are often difficult to differentiate from parkinson\u2019s disease and each other. Although these syndromes are clinically distinct, modern immunocytochemical techniques and new genetic findings have revealed intriguing interconnections at a basic molecular level, providing a scientific rationale for lumping […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-28633","post","type-post","status-publish","format-standard","hentry","category-p"],"yoast_head":"\n\u201cParkinson\u2019s Plus\u201d syndromes - Definition of \u201cParkinson\u2019s Plus\u201d syndromes<\/title>\n<meta name=\"description\" content=\"The atypical parkinsonian syndromes\u2014dementia with lewy bodies, multiple system atrophy, progressive supranuclear palsy, and corticobasal ganglionic degeneration\u2014are often difficult to differentiate from parkinson\u2019s disease and each other. Although these syndromes are clinically distinct, modern immunocytochemical techniques and new genetic findings have revealed intriguing interconnections at a basic molecular level, providing a scientific rationale for lumping these diseases into two groups, the synucleinopathies and the tauopathies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/parkinsons-plus-syndromes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u201cParkinson\u2019s Plus\u201d syndromes - Definition of \u201cParkinson\u2019s Plus\u201d syndromes\" \/>\n<meta property=\"og:description\" content=\"The atypical parkinsonian syndromes\u2014dementia with lewy bodies, multiple system atrophy, progressive supranuclear palsy, and corticobasal ganglionic degeneration\u2014are often difficult to differentiate from parkinson\u2019s disease and each other. Although these syndromes are clinically distinct, modern immunocytochemical techniques and new genetic findings have revealed intriguing interconnections at a basic molecular level, providing a scientific rationale for lumping these diseases into two groups, the synucleinopathies and the tauopathies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/parkinsons-plus-syndromes\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-14T10:09:58+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/parkinsons-plus-syndromes\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/parkinsons-plus-syndromes\/\",\"name\":\"\u201cParkinson\u2019s Plus\u201d syndromes - Definition of \u201cParkinson\u2019s Plus\u201d syndromes\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-07-14T10:09:58+00:00\",\"dateModified\":\"2020-07-14T10:09:58+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"The atypical parkinsonian syndromes\u2014dementia with lewy bodies, multiple system atrophy, progressive supranuclear palsy, and corticobasal ganglionic degeneration\u2014are often difficult to differentiate from parkinson\u2019s disease and each other. Although these syndromes are clinically distinct, modern immunocytochemical techniques and new genetic findings have revealed intriguing interconnections at a basic molecular level, providing a scientific rationale for lumping these diseases into two groups, the synucleinopathies and the tauopathies.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/parkinsons-plus-syndromes\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/parkinsons-plus-syndromes\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/parkinsons-plus-syndromes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u201cParkinson\u2019s Plus\u201d syndromes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u201cParkinson\u2019s Plus\u201d syndromes - Definition of \u201cParkinson\u2019s Plus\u201d syndromes","description":"The atypical parkinsonian syndromes\u2014dementia with lewy bodies, multiple system atrophy, progressive supranuclear palsy, and corticobasal ganglionic degeneration\u2014are often difficult to differentiate from parkinson\u2019s disease and each other. Although these syndromes are clinically distinct, modern immunocytochemical techniques and new genetic findings have revealed intriguing interconnections at a basic molecular level, providing a scientific rationale for lumping these diseases into two groups, the synucleinopathies and the tauopathies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/parkinsons-plus-syndromes\/","og_locale":"en_US","og_type":"article","og_title":"\u201cParkinson\u2019s Plus\u201d syndromes - Definition of \u201cParkinson\u2019s Plus\u201d syndromes","og_description":"The atypical parkinsonian syndromes\u2014dementia with lewy bodies, multiple system atrophy, progressive supranuclear palsy, and corticobasal ganglionic degeneration\u2014are often difficult to differentiate from parkinson\u2019s disease and each other. Although these syndromes are clinically distinct, modern immunocytochemical techniques and new genetic findings have revealed intriguing interconnections at a basic molecular level, providing a scientific rationale for lumping these diseases into two groups, the synucleinopathies and the tauopathies.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/parkinsons-plus-syndromes\/","og_site_name":"Glossary","article_published_time":"2020-07-14T10:09:58+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/parkinsons-plus-syndromes\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/parkinsons-plus-syndromes\/","name":"\u201cParkinson\u2019s Plus\u201d syndromes - Definition of \u201cParkinson\u2019s Plus\u201d syndromes","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-07-14T10:09:58+00:00","dateModified":"2020-07-14T10:09:58+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"The atypical parkinsonian syndromes\u2014dementia with lewy bodies, multiple system atrophy, progressive supranuclear palsy, and corticobasal ganglionic degeneration\u2014are often difficult to differentiate from parkinson\u2019s disease and each other. Although these syndromes are clinically distinct, modern immunocytochemical techniques and new genetic findings have revealed intriguing interconnections at a basic molecular level, providing a scientific rationale for lumping these diseases into two groups, the synucleinopathies and the tauopathies.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/parkinsons-plus-syndromes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/parkinsons-plus-syndromes\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/parkinsons-plus-syndromes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"\u201cParkinson\u2019s Plus\u201d syndromes"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/28633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=28633"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/28633\/revisions"}],"predecessor-version":[{"id":28634,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/28633\/revisions\/28634"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=28633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=28633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=28633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}